JULY 2023LIFE SCIENCES REVIEW4CONTENTSCONTENTSBiotechnology should have Preferred Regulatory Pathways to Catalyze the Bioscience RevolutionErika Vento-Gaudens, Director, Global Clinical Trial Operations, Guardant HealthIN MY OPINIONLAST WORD3012CO V ER S T O R Y08Clinical Trial Diversity in HIV ­ What's the problem?Sherene Shakib Min, MD, MPH, VP, Head of Global Clinical Development, ViiV HealthcareA GLIMPSE INTO THE FUTURE OF RARE DISEASES DRUG DEVELOPMENT: THE LATEST ADVANCES AND INNOVATIONSSAFWAN KEZBOR, M.D., SENIOR MEDICAL DIRECTOR, CLINICAL DEVELOPMENT,SHIONOGI
< Page 3 | Page 5 >